Celldex (CLDX) Misses Q3 EPS by 13c

Celldex (NASDAQ: CLDX) reported Q3 EPS of ($0.81), $0.13 worse than the analyst estimate of ($0.68). Revenue for the quarter came in at $1.51 million versus the consensus estimate of $583.33 thousand.

For earnings history and earnings-related data on Celldex (CLDX) click here.

You May Also Be Interested In

• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• Jefferies Financial Group (JEF) Misses Q2 EPS by 22c
• Rheinmetall AG (RHM:GR) (RNMBY) PT Lowered to EUR1,750 at Morgan Stanley